Everly Health Aquires Women’s Health Brand Natalist

The acquisition brings Natalist's range of fertility and pregnancy essentials into Everly Health's portfolio of women's health offerings

Everly Health the digital health company at the forefront of the virtual diagnostics-driven care industry, today announced its acquisition of Natalist, a women’s health company that offers consumers conception and pregnancy essentials that are thoughtfully designed for ease of use and are 100% plastic neutral. Natalist is the third acquisition by Everly Health this year. Terms of the all-cash transaction were not disclosed.

“Creating innovative solutions for women’s health was my initial motivation for founding Everlywell and remains a top area of focus,” said Julia Cheek, CEO and Founder of Everly Health. “A survey of our customers revealed that nearly 70% don’t trust many of the women’s health products available on the market today.1 Natalist’s thoughtfully designed fertility and pregnancy essentials are the solution that so many women are seeking.”

Since its launch two years ago, Natalist has progressively expanded its product line to support women on their reproductive journeys, both online and in national retailers. The brand’s footprint has grown from 300 to nearly 6,000 brick-and-mortar locations in just the last year.

Both Natalist and Everly Health are led and founded by moms and advised by board-certified physicians. As part of the transaction, Natalist’s full team and executive leadership have joined Everly Health, bringing the company’s portfolio to four subsidiaries: Natalist, Everly Health Solutions, EverlyDx, and Everlywell, the leading brand in at-home collection health and wellness lab testing in the U.S. today.2

“Natalist was created to serve people who are seeking modern, sustainable tools for conception and pregnancy. Everly Health’s full capabilities across testing, telehealth, and virtual care delivery will supercharge our ability to help people in ways we’re only beginning to explore,” stated Vernita Brown, Chief Executive Officer at Natalist. “I’m thrilled to discover what we can accomplish together, as part of Everly Health.”

In addition to its signature pregnancy and ovulation tests, Natalist’s product suite supports women from pre-conception through pregnancy and includes tests, supplements, education, lubricants, and self-care items. Today, Natalist’s most popular products include its Ovulation Tests, Pregnancy Tests, and Prenatal supplements. Natalist’s products expand Everlywell’s existing women’s health offering that includes at-home collection lab tests for menopause, fertility hormones, sexual health, and more. Everlywell was also the first company to launch an at-home collection fertility hormone test to consumers in March 2018.

“Last year, millions of women discovered at-home testing, telehealth, and wellness solutions for the first time — ideal solutions for the busy lives women lead. In fact, Everlywell’s Women’s Health suite of tests has seen a 350% increase in sales this year,” said Jenifer Dasho, Chief Marketing Officer at Everly Health and General Manager of Natalist. “For the millions of women who changed their plans to grow their families due to the pandemic,3 home-based health and wellness solutions are a powerful tool to help gain control over their reproductive journey.”

“The missions of our two companies have been aligned since day one. We’re working to make sure all people — especially women — have access to care that’s simple, convenient, and designed for the way they live,” remarked Halle Tecco, Founder and Chief Women’s Health Officer at Natalist. “Bringing together two brands that are founded and led by women to benefit women everywhere is a great feeling.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy